Literature DB >> 24412394

Autoinhibitory structure of the WW domain of HYPB/SETD2 regulates its interaction with the proline-rich region of huntingtin.

Yong-Guang Gao1, Hui Yang2, Jian Zhao2, Ya-Jun Jiang2, Hong-Yu Hu3.   

Abstract

Huntington's disease (HD) is an autosomally dominant neurodegenerative disorder caused by expansion of polyglutamine (polyQ) in the huntingtin (Htt) protein. Htt yeast two-hybrid protein B (HYPB/SETD2), a histone methyltransferase, directly interacts with Htt and is involved in HD pathology. Using NMR techniques, we characterized a polyproline (polyP) stretch at the C terminus of HYPB, which directly interacts with the following WW domain and leads this domain predominantly to be in a closed conformational state. The solution structure shows that the polyP stretch extends from the back and binds to the WW core domain in a typical binding mode. This autoinhibitory structure regulates interaction between the WW domain of HYPB and the proline-rich region (PRR) of Htt, as evidenced by NMR and immunofluorescence techniques. This work provides structural and mechanistic insights into the intramolecular regulation of the WW domain in Htt-interacting partners and will be helpful for understanding the pathology of HD.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24412394     DOI: 10.1016/j.str.2013.12.005

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  14 in total

1.  Protofilament Structure and Supramolecular Polymorphism of Aggregated Mutant Huntingtin Exon 1.

Authors:  Jennifer C Boatz; Talia Piretra; Alessia Lasorsa; Irina Matlahov; James F Conway; Patrick C A van der Wel
Journal:  J Mol Biol       Date:  2020-06-27       Impact factor: 5.469

Review 2.  Histone methyltransferases: novel targets for tumor and developmental defects.

Authors:  Xin Yi; Xue-Jun Jiang; Xiao-Yan Li; Ding-Sheng Jiang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

Review 3.  SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.

Authors:  Catherine C Fahey; Ian J Davis
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

Review 4.  Shaping the cellular landscape with Set2/SETD2 methylation.

Authors:  Stephen L McDaniel; Brian D Strahl
Journal:  Cell Mol Life Sci       Date:  2017-04-06       Impact factor: 9.261

5.  Aggregation of Polyglutamine-expanded Ataxin 7 Protein Specifically Sequesters Ubiquitin-specific Protease 22 and Deteriorates Its Deubiquitinating Function in the Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex.

Authors:  Hui Yang; Shuai Liu; Wen-Tian He; Jian Zhao; Lei-Lei Jiang; Hong-Yu Hu
Journal:  J Biol Chem       Date:  2015-07-20       Impact factor: 5.157

6.  Balancing acts of SRI and an auto-inhibitory domain specify Set2 function at transcribed chromatin.

Authors:  Yi Wang; Yanling Niu; Bing Li
Journal:  Nucleic Acids Res       Date:  2015-04-29       Impact factor: 16.971

7.  Polyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance.

Authors:  Cody L Hoop; Hsiang-Kai Lin; Karunakar Kar; Zhipeng Hou; Michelle A Poirier; Ronald Wetzel; Patrick C A van der Wel
Journal:  Biochemistry       Date:  2014-10-16       Impact factor: 3.162

8.  Changes in the folding landscape of the WW domain provide a molecular mechanism for an inherited genetic syndrome.

Authors:  Encarna Pucheta-Martinez; Nicola D'Amelio; Moreno Lelli; Jorge L Martinez-Torrecuadrada; Marius Sudol; Giorgio Saladino; Francesco Luigi Gervasio
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

9.  Control of the structural landscape and neuronal proteotoxicity of mutant Huntingtin by domains flanking the polyQ tract.

Authors:  Koning Shen; Barbara Calamini; Jonathan A Fauerbach; Boxue Ma; Sarah H Shahmoradian; Ivana L Serrano Lachapel; Wah Chiu; Donald C Lo; Judith Frydman
Journal:  Elife       Date:  2016-10-18       Impact factor: 8.140

Review 10.  SETD2: an epigenetic modifier with tumor suppressor functionality.

Authors:  Jun Li; Gerben Duns; Helga Westers; Rolf Sijmons; Anke van den Berg; Klaas Kok
Journal:  Oncotarget       Date:  2016-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.